SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER

被引：0
|
作者：
Kashiwagi, S. [1 ]
Yashiro, M. [1 ]
Aomatsu, N. [1 ]
Kawajiri, H. [1 ]
Takashima, T. [1 ]
Onoda, N. [1 ]
Ishikawa, T. [1 ]
Hirakawa, K. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [21] Identification of BBOX1 as a therapeutic target in triple-negative breast cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER RESEARCH, 2021, 81 (04)
  • [22] CDC20 is a novel therapeutic target in triple-negative breast cancer
    Sharma, Jayesh K.
    Alluri, Prasanna
    Udden, Nashir
    CANCER RESEARCH, 2020, 80 (16)
  • [23] LRP5: a potential therapeutic target in triple-negative breast cancer
    Maubant, Sylvie
    Maire, Virginie
    Tesson, Bruno
    Gentien, David
    Marty-Prouvost, Berengere
    Cruzalegui, Francisco
    Depil, Stephane
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    CANCER RESEARCH, 2013, 73 (08)
  • [24] PIM1 MAY BE A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    不详
    CANCER DISCOVERY, 2016, 6 (12) : 1303 - 1303
  • [25] c-Met: A Promising Therapeutic Target in Bladder Cancer
    Feng, Yanfei
    Yang, Zitong
    Xu, Xin
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2379 - 2388
  • [26] Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER DISCOVERY, 2020, 10 (11) : 1706 - 1721
  • [27] NOTCH4 Is a Potential Therapeutic Target for Triple-negative Breast Cancer
    Nagamatsu, Iori
    Onishi, Hideya
    Matsushita, Shojiro
    Kubo, Makoto
    Kai, Masaya
    Imaizumi, Akira
    Nakano, Kenji
    Hattori, Masami
    Oda, Yoshinao
    Tanaka, Masao
    Katano, Mitsuo
    ANTICANCER RESEARCH, 2014, 34 (1A) : 69 - 80
  • [28] Overexpression of EGFR and c-MET in Triple Negative Breast Cancer Is Associated with Poor Prognosis
    Witkiewicz, A. K.
    Lipinski, R. L.
    Solomides, C.
    Peiper, S.
    MODERN PATHOLOGY, 2012, 25 : 73A - 73A
  • [29] Overexpression of EGFR and c-MET in Triple Negative Breast Cancer Is Associated with Poor Prognosis
    Witkiewicz, A. K.
    Lipinski, R. L.
    Solomides, C.
    Peiper, S.
    LABORATORY INVESTIGATION, 2012, 92 : 73A - 73A
  • [30] The significance of the androgen receptor in triple-negative breast cancer: to be or not to be
    Chifu, M. B.
    Caruntu, I.
    Giusca, S. E.
    Gafton, B.
    Terinte, C.
    Timofte, A. D.
    Amalinei, C.
    Prutianu, I.
    VIRCHOWS ARCHIV, 2024, 485 : S52 - S53
12345